Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma. (Q53462221)

14 May 2018

title

Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma. (English)

1 reference

14 May 2018

author name string

Ambrosi Pertia

1

1 reference

14 May 2018

David Nikoleishvili

2

1 reference

14 May 2018

Omar Trsintsadze

3

1 reference

14 May 2018

Nino Gogokhia

4

1 reference

14 May 2018

Laurent Managadze

5

1 reference

14 May 2018

Archil Chkhotua

6

1 reference

14 May 2018

publication date

5 August 2008

1 reference

14 May 2018

International Urology and Nephrology

published in

1 reference

14 May 2018

volume

41

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

243-249

1 reference

14 May 2018

Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-008-9442-8

Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D

21 January 2018

1 reference

12 December 2020

Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters

1 reference

12 December 2020

Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance

1 reference

12 December 2020

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

1 reference

12 December 2020

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

1 reference

12 December 2020

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

1 reference

12 December 2020

Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma

1 reference

12 December 2020

Unrestricted cell cycling and cancer

1 reference

12 December 2020

Tumor markers for renal cell carcinoma

1 reference

12 December 2020

Prognostic factors in renal cell carcinoma

1 reference

12 December 2020

Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor

1 reference

12 December 2020

Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney

1 reference

12 December 2020

The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?

1 reference

12 December 2020

Staging of renal cell carcinoma: current concepts

1 reference

12 December 2020

Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry

1 reference

12 December 2020

Reexamination of current staging for renal cell carcinoma

1 reference

12 December 2020

Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique

1 reference

12 December 2020

Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma

1 reference

12 December 2020

Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene

1 reference

12 December 2020

Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma

1 reference

12 December 2020

TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

12 December 2020

The changing natural history of renal cell carcinoma

1 reference

12 December 2020

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma

1 reference

12 December 2020

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

1 reference

12 December 2020

1 reference

12 December 2020

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.

1 reference

12 December 2020

10.1007/S11255-008-9442-8

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

18679818

1 reference

14 May 2018